Health Monitor Monaco: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Monaco.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 11, 2026

January 11, 2026

Zymeworks Outlines Strategic Priorities and Outlook for 2026

GlobeNewswire

January 11, 2026

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

GlobeNewswire

January 11, 2026

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire

January 11, 2026

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire

January 11, 2026

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

GlobeNewswire

January 11, 2026

HealthEx Partners with Anthropic to Turn Patients’ Scattered Medical Records into Actionable Health Insights

GlobeNewswire

January 11, 2026

Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

GlobeNewswire

January 11, 2026

MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 11, 2026

Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results

GlobeNewswire

January 11, 2026

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 11, 2026

Exagen Inc. Announces Select Preliminary 2025 Financial Results

GlobeNewswire

January 11, 2026

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 11, 2026

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

GlobeNewswire

January 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

GlobeNewswire